I agree that this site is using cookies. You can find further informations here.
X
Mangaonkar, Abhishek
67  results:
OpenAccess-fulltext X
?
1

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) d..:

Bezerra, Evandro ; Lasho, Terra ; Finke, Christy...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41408-021-00449-9.  , 2021
Link: https://hal.science/hal-..
 
?
2

RAS mutations drive proliferative chronic myelomonocytic le..:

Carr, Ryan ; Vorobyev, Denis ; Lasho, Terra...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41467-021-23186-w.  , 2021
Link: https://hal.science/hal-..
 
?
3

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) d..:

Bezerra, Evandro ; Lasho, Terra ; Finke, Christy...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41408-021-00449-9.  , 2021
Link: https://hal.science/hal-..
 
?
4

P722: CHARACTERISATION OF PHF6 MUTATIONS IN MYELOID NEOPLAS..:

Amrutha Sai Mittapalli ; Bahga Katamesh ; Muhamad Oum...
http://journals.lww.com/10.1097/01.HS9.0000969792.87570.30.  , 2023
Link: https://doi.org/10.1097/..
 
?
5

U2AF1 pathogenic variants in myeloid neoplasms and precurso..:

Talha Badar ; Yenny A. Moreno Vanegas ; Ahmad Nanaa...
https://doi.org/10.1038/s41408-023-00922-7.  , 2023
Link: https://doi.org/10.1038/..
 
?
6

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUT..:

Rami Basmaci ; Anmol Baranwal ; Rong He...
http://journals.lww.com/10.1097/01.HS9.0000969224.84724.f8.  , 2023
Link: https://doi.org/10.1097/..
 
?
7

P1346: THE IMPACT OF CYTOTOXIC THERAPY ON THE RISK OF PROGR..:

LI Marissa ; Anmol Baranwal ; Syed Shah...
http://journals.lww.com/10.1097/01.HS9.0000972272.06849.81.  , 2023
Link: https://doi.org/10.1097/..
 
?
8

Abnormal karyotype is an independent predictor of inferior ..:

Mostafa Abdallah ; Kristen McCullough ; Rimal Ilyas...
https://doi.org/10.1038/s41408-023-00812-y.  , 2023
Link: https://doi.org/10.1038/..
 
?
9

P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2-MUTATED ..:

Muhamad Oum ; Ahmad Nanaa ; Amrutha Mittapalli...
http://journals.lww.com/10.1097/01.HS9.0000969892.81209.ff.  , 2023
Link: https://doi.org/10.1097/..
 
?
10

Observation and treatment in DDX41-mutated acute myeloid le..:

Aref Al-Kali ; Ahmad Nanaa ; David Viswanatha...
https://doi.org/10.1038/s41408-023-00818-6.  , 2023
Link: https://doi.org/10.1038/..
 
?
11

P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID ..:

Bahga Katamesh ; Ahmad Nanaa ; Rong He...
http://journals.lww.com/10.1097/01.HS9.0000969840.65989.e7.  , 2023
Link: https://doi.org/10.1097/..
 
?
12

P709: H2AK119UB IN THE TRANSCRIPTIONAL REGULATION OF PATIEN..:

Moritz Binder ; Liguo Wang ; Stephanie Safgren...
http://journals.lww.com/10.1097/01.HS9.0000969740.55931.44.  , 2023
Link: https://doi.org/10.1097/..
 
?
13

CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferati..:

Rimal Ilyas ; Kristen McCullough ; Talha Badar...
https://doi.org/10.1038/s41408-023-00800-2.  , 2023
Link: https://doi.org/10.1038/..
 
?
14

Oncogenic gene expression and epigenetic remodeling of cis-..:

Moritz Binder ; Ryan M. Carr ; Terra L. Lasho...
https://doi.org/10.1038/s41467-022-29142-6.  , 2022
Link: https://doi.org/10.1038/..
 
?
15

Therapy-related clonal cytopenia as a precursor to therapy-..:

Mithun Vinod Shah ; Abhishek A. Mangaonkar ; Kebede H. Begna...
https://doi.org/10.1038/s41408-022-00703-8.  , 2022
Link: https://doi.org/10.1038/..
 
1-15